Emerging bronchoscopic therapies offer minimally invasive treatment options for COPD, filling a gap left by traditional ...

Upstream Bio is leveraging TSLP targeting for respiratory disorders treatment, with IPO funds and upcoming Chronic ...

The first-in class medicine for severe asthma co ... patients with a history of asthma exacerbations and uncontrolled asthma receiving currently approved inhaled treatment versus placebo.

its use is restricted within the allergic asthma subtype. The treatment of an already established exacerbation is more straight forward than its prevention. It comprises of oxygenation ...

Ian Pavord, professor of respiratory medicine at Oxford University, said: “Despite the availability of current treatment options, many patients with severe eosinophilic asthma still experience ...

NEW DELHI: Biologic therapies are revolutionising severe asthma management, showcasing potential for remission, but cost and equitable access are the major barriers, according to a report on Tuesday.

has been studied in severe asthmatics and in COPD patients with a history of asthma, showing an additional bronchodilator effect on top of the current asthma treatment. The first large study on ...

KKH and the National Skin Centre say there are more such patients, but no recent studies have been done. Read more at ...

The prevalence of eczema in Singapore has been largely stable in the past decade, affecting about one in five children and ...

BOTOX ® (onabotulinumtoxinA) is a prescription medicine that is injected into muscles and used to prevent headaches in adults ...

It's the holiday season, which means it's respiratory virus season. Here's what you need to know about the flu, COVID-19 and ...